{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:55:06Z","timestamp":1789055706010,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03649-5","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:14:15Z","timestamp":1752898455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SIGLEC1 ubiquitination and degradation induced by MARCHF3 protects ARPE19 retinal cells from high glucose-induced oxidative stress, inflammation, and apoptosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Xihong","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"10","key":"3649_CR1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11892-021-01404-5","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) Association between diabetes, diabetic retinopathy, and glaucoma. Curr Diab Rep 21(10):38","journal-title":"Curr Diab Rep"},{"issue":"1","key":"3649_CR2","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ et al (2020) Diabetic retinopathy preferred practice pattern\u00ae. Ophthalmology 127(1):P66-p145","journal-title":"Ophthalmology"},{"issue":"5","key":"3649_CR3","doi-asserted-by":"crossref","first-page":"C1061","DOI":"10.1152\/ajpcell.00188.2022","volume":"324","author":"G Kaur","year":"2023","unstructured":"Kaur G, Harris NR (2023) Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy. Am J Physiol Cell Physiol 324(5):C1061-c1077","journal-title":"Am J Physiol Cell Physiol"},{"key":"3649_CR4","doi-asserted-by":"crossref","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C (2020) Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 37:101799","journal-title":"Redox Biol"},{"key":"3649_CR5","doi-asserted-by":"crossref","first-page":"583687","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester JV, Kuffova L, Delibegovic M (2020) The role of inflammation in diabetic retinopathy. Front Immunol 11:583687","journal-title":"Front Immunol"},{"key":"3649_CR6","doi-asserted-by":"crossref","first-page":"1055087","DOI":"10.3389\/fimmu.2022.1055087","volume":"13","author":"T Yue","year":"2022","unstructured":"Yue T et al (2022) The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol 13:1055087","journal-title":"Front Immunol"},{"issue":"18","key":"3649_CR7","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.2174\/0115701808342987241216081153","volume":"21","author":"A Ashima","year":"2024","unstructured":"Ashima A, Yogesh M, Sonia S (2024) Exploring the potential of artificial intelligence in medical research: applications, regulatory concerns, opportunities and future outlook- a mini review. Lett Drug Des Discovery 21(18):4205\u20134220","journal-title":"Lett Drug Des Discovery"},{"issue":"3","key":"3649_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14728214.2020.1801631","volume":"25","author":"E Striglia","year":"2020","unstructured":"Striglia E et al (2020) Emerging drugs for the treatment of diabetic retinopathy. Expert Opin Emerg Drugs 25(3):261\u2013271","journal-title":"Expert Opin Emerg Drugs"},{"key":"3649_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exer.2013.09.015","volume":"126","author":"VL Bonilha","year":"2014","unstructured":"Bonilha VL (2014) Retinal pigment epithelium (RPE) cytoskeleton in vivo and in vitro. Exp Eye Res 126:38\u201345","journal-title":"Exp Eye Res"},{"key":"3649_CR10","doi-asserted-by":"crossref","first-page":"100919","DOI":"10.1016\/j.preteyeres.2020.100919","volume":"83","author":"D Tonade","year":"2021","unstructured":"Tonade D, Kern TS (2021) Photoreceptor cells and RPE contribute to the development of diabetic retinopathy. Prog Retin Eye Res 83:100919","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"3649_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/db24-0040","volume":"74","author":"K Nishikawa","year":"2025","unstructured":"Nishikawa K et al (2025) Extracellular mitochondria exacerbate retinal pigment epithelium degeneration in diabetic retinopathy. Diabetes 74(3):409\u2013415","journal-title":"Diabetes"},{"key":"3649_CR12","doi-asserted-by":"crossref","first-page":"979373","DOI":"10.3389\/fmed.2022.979373","volume":"9","author":"S Herzog","year":"2022","unstructured":"Herzog S et al (2022) Myeloid CD169\/Siglec1: an immunoregulatory biomarker in viral disease. Front Med (Lausanne) 9:979373","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"3649_CR13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10753-017-0562-0","volume":"40","author":"D Wang","year":"2017","unstructured":"Wang D et al (2017) Macrophage subset expressing CD169 in peritoneal cavity-regulated mucosal inflammation together with lower levels of CCL22. Inflammation 40(4):1191\u20131203","journal-title":"Inflammation"},{"issue":"1","key":"3649_CR14","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1038\/s41598-021-89786-0","volume":"11","author":"L Ostendorf","year":"2021","unstructured":"Ostendorf L et al (2021) SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients. Sci Rep 11(1):10299","journal-title":"Sci Rep"},{"issue":"1","key":"3649_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-21-0453","volume":"255","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) The role of activated monocyte IFN\/SIGLEC1 signalling in Graves\u2019 disease. J Endocrinol 255(1):1\u20139","journal-title":"J Endocrinol"},{"issue":"10","key":"3649_CR16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/cr.2015.108","volume":"25","author":"Q Zheng","year":"2015","unstructured":"Zheng Q et al (2015) Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res 25(10):1121\u20131136","journal-title":"Cell Res"},{"issue":"4","key":"3649_CR17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00125-024-06098-4","volume":"67","author":"M Guo","year":"2024","unstructured":"Guo M et al (2024) A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Diabetologia 67(4):623\u2013640","journal-title":"Diabetologia"},{"key":"3649_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2018.06.003","volume":"195","author":"R Hu","year":"2018","unstructured":"Hu R et al (2018) Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clin Immunol 195:139\u2013148","journal-title":"Clin Immunol"},{"issue":"11","key":"3649_CR19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20(11):1242\u20131253","journal-title":"Nat Med"},{"issue":"4","key":"3649_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/ijms24043219","volume":"24","author":"H Kitamura","year":"2023","unstructured":"Kitamura H (2023) Ubiquitin-specific proteases (USPs) and metabolic disorders. Int J Mol Sci 24(4):635","journal-title":"Int J Mol Sci"},{"key":"3649_CR21","doi-asserted-by":"crossref","first-page":"e13715","DOI":"10.7717\/peerj.13715","volume":"10","author":"Z Svikle","year":"2022","unstructured":"Svikle Z et al (2022) Ubiquitin-proteasome system in diabetic retinopathy. PeerJ 10:e13715","journal-title":"PeerJ"},{"issue":"12","key":"3649_CR22","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/s41423-021-00799-1","volume":"18","author":"H Lin","year":"2021","unstructured":"Lin H et al (2021) The membrane-associated E3 ubiquitin ligase MARCH3 downregulates the IL-6 receptor and suppresses colitis-associated carcinogenesis. Cell Mol Immunol 18(12):2648\u20132659","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"3649_CR23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41423-022-00907-9","volume":"19","author":"LW Zeng","year":"2022","unstructured":"Zeng LW et al (2022) The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target IL-5 receptor alpha to negatively regulate eosinophilic airway inflammation. Cell Mol Immunol 19(10):1117\u20131129","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"3649_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/biom12070925","volume":"12","author":"Z Stekel","year":"2022","unstructured":"Stekel Z, Sheng Y, Zhang W (2022) The multifaceted role of the ubiquitin proteasome system in pathogenesis and diseases. Biomolecules 12(7):65","journal-title":"Biomolecules"},{"issue":"3","key":"3649_CR25","doi-asserted-by":"crossref","first-page":"112171","DOI":"10.1016\/j.celrep.2023.112171","volume":"42","author":"ST Yeung","year":"2023","unstructured":"Yeung ST et al (2023) CD169+ macrophage intrinsic IL-10 production regulates immune homeostasis during sepsis. Cell Rep 42(3):112171","journal-title":"Cell Rep"},{"issue":"85","key":"3649_CR26","doi-asserted-by":"crossref","first-page":"eadg0033","DOI":"10.1126\/sciimmunol.adg0033","volume":"8","author":"EG Viox","year":"2023","unstructured":"Viox EG et al (2023) Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. Sci Immunol 8(85):eadg0033","journal-title":"Sci Immunol"},{"issue":"8","key":"3649_CR27","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1093\/rheumatology\/keab875","volume":"61","author":"L Zorn-Pauly","year":"2022","unstructured":"Zorn-Pauly L et al (2022) Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. Rheumatology (Oxford) 61(8):3396\u20133400","journal-title":"Rheumatology (Oxford)"},{"issue":"49","key":"3649_CR28","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.1806217115","volume":"115","author":"H Lin","year":"2018","unstructured":"Lin H et al (2018) MARCH3 attenuates IL-1\u03b2-triggered inflammation by mediating K48-linked polyubiquitination and degradation of IL-1RI. Proc Natl Acad Sci U S A 115(49):12483\u201312488","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"3649_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/MCB.00104-20","volume":"40","author":"LM Williams","year":"2020","unstructured":"Williams LM, Gilmore TD (2020) Looking down on NF-\u03baB. Mol Cell Biol 40(15):214","journal-title":"Mol Cell Biol"},{"key":"3649_CR30","doi-asserted-by":"crossref","first-page":"831660","DOI":"10.3389\/fimmu.2022.831660","volume":"13","author":"L Tang","year":"2022","unstructured":"Tang L et al (2022) Melatonin maintains inner blood-retinal barrier by regulating microglia via inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB signaling pathways in experimental diabetic retinopathy. Front Immunol 13:831660","journal-title":"Front Immunol"},{"issue":"Pt 1","key":"3649_CR31","doi-asserted-by":"crossref","first-page":"117135","DOI":"10.1016\/j.jep.2023.117135","volume":"319","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: association with the NF-\u03baB signaling pathway. J Ethnopharmacol 319(Pt 1):117135","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"3649_CR32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta L et al (2019) Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell 35(4):588-602.e10","journal-title":"Cancer Cell"},{"issue":"12","key":"3649_CR33","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1167\/iovs.08-2117","volume":"49","author":"J Sancho-Pelluz","year":"2008","unstructured":"Sancho-Pelluz J et al (2008) Sialoadhesin expression in intact degenerating retinas and following transplantation. Invest Ophthalmol Vis Sci 49(12):5602\u20135610","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3649_CR34","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.4049\/jimmunol.177.4.2258","volume":"177","author":"HR Jiang","year":"2006","unstructured":"Jiang HR et al (2006) Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis. J Immunol 177(4):2258\u20132264","journal-title":"J Immunol"},{"issue":"21","key":"3649_CR35","doi-asserted-by":"crossref","first-page":"e00972","DOI":"10.1128\/JVI.00972-17","volume":"91","author":"H Akiyama","year":"2017","unstructured":"Akiyama H et al (2017) Interferon-Inducible CD169\/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon. J Virol 91(21):e00972-17","journal-title":"J Virol"},{"issue":"1","key":"3649_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-21-0453","volume":"255","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) The role of activated monocyte IFN\/SIGLEC1 signalling in Graves' disease. J Endocrinol 255(1):1-9.","journal-title":"J Endocrinol"},{"issue":"1","key":"3649_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41392-021-00834-7","volume":"7","author":"L Feng","year":"2022","unstructured":"Feng L et al (2022) MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3R\u03b1. Signal Transduct Target Ther 7(1):21","journal-title":"Signal Transduct Target Ther"},{"key":"3649_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2023.04.020","volume":"664","author":"X Xiaoling","year":"2023","unstructured":"Xiaoling X et al (2023) TRIM40 ameliorates diabetic retinopathy through suppressing inflammation via Reelin\/DAB1 signaling disruption: a mechanism by proteasomal degradation of DAB1. Biochem Biophys Res Commun 664:117\u2013127","journal-title":"Biochem Biophys Res Commun"},{"key":"3649_CR39","doi-asserted-by":"crossref","first-page":"111225","DOI":"10.1016\/j.cellsig.2024.111225","volume":"120","author":"H Guo","year":"2024","unstructured":"Guo H et al (2024) USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination. Cell Signal 120:111225","journal-title":"Cell Signal"},{"issue":"23","key":"3649_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ijms21239181","volume":"21","author":"P Poma","year":"2020","unstructured":"Poma P (2020) NF-\u03baB and disease. Int J Mol Sci 21(23):63","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3649_CR41","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.3390\/ijms241310550","volume":"24","author":"E Bang","year":"2023","unstructured":"Bang E et al (2023) Spermidine attenuates high glucose-induced oxidative damage in retinal pigment epithelial cells by inhibiting production of ROS and NF-\u03baB\/NLRP3 inflammasome pathway. Int J Mol Sci 24(13):2457","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3649_CR42","first-page":"6547","volume":"12","author":"C Park","year":"2023","unstructured":"Park C et al (2023) \u03b2-asarone alleviates high-glucose-induced oxidative damage via inhibition of ROS generation and inactivation of the NF-\u03baB\/NLRP3 inflammasome pathway in human retinal pigment epithelial cells. Antioxidants (Basel) 12(7):6547","journal-title":"Antioxidants (Basel)"},{"key":"3649_CR43","doi-asserted-by":"crossref","unstructured":"Lim RR et al (2024) ITF2357 regulates NF-\u03baB signaling pathway to protect barrier integrity in retinal pigment epithelial cells. FASEB J 38(5):e23512","DOI":"10.1096\/fj.202301592R"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03649-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03649-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03649-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:06:12Z","timestamp":1766167572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03649-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3649"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03649-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"298"}}